Literature DB >> 4320120

Metabolic and toxic effects of mithramycin during tumor therapy.

B J Kennedy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4320120     DOI: 10.1016/s0002-9343(70)80044-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  21 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Chemotherapy-associated renal dysfunction.

Authors:  Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Rev Nephrol       Date:  2009-06-30       Impact factor: 28.314

3.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

Review 4.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 5.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

6.  The effect of two diphosphonates on the resorption of mouse calvaria in vitro.

Authors:  J J Reynolds; C Minkin; D B Morgan; D Spycher; H Fleisch
Journal:  Calcif Tissue Res       Date:  1972

Review 7.  Cancer, chemotherapy and anaesthesia.

Authors:  F Chung
Journal:  Can Anaesth Soc J       Date:  1982-07

8.  Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.

Authors:  M J Soble; R T Dorr; P Plezia; S Breckenridge
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 9.  Principles of management of osteometabolic disorders affecting the aging spine.

Authors:  Alexander G Hadjipavlou; Paul G Katonis; Michael N Tzermiadianos; George M Tsoukas; George Sapkas
Journal:  Eur Spine J       Date:  2003-09-23       Impact factor: 3.134

10.  Semi-synthetic mithramycin SA derivatives with improved anticancer activity.

Authors:  Daniel Scott; Jhong-Min Chen; Younsoo Bae; Jürgen Rohr
Journal:  Chem Biol Drug Des       Date:  2013-04-04       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.